Efficacy of Transcutaneous Electrical Acupoint Stimulation as a Preventive Measure Against Lymphedema in Breast Cancer Patients Undergoing Axillary Lymph Node Dissection: A Protocol for a Randomized Controlled Trial - Summary - MDSpire
Advertisement
Efficacy of Transcutaneous Electrical Acupoint Stimulation as a Preventive Measure Against Lymphedema in Breast Cancer Patients Undergoing Axillary Lymph Node Dissection: A Protocol for a Randomized Controlled Trial
To evaluate the efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) as a preventive measure against breast cancer-related lymphedema (BCRL) in patients undergoing axillary lymph node dissection, emphasizing the importance of addressing this common complication.
Key Findings:
BCRL is a common complication post-breast cancer surgery, with incidence rates between 6% to 63%, highlighting the need for effective preventive measures.
TEAS may serve as a non-invasive adjunct therapy for preventing BCRL if proven effective, potentially improving patient outcomes.
Interpretation:
The study aims to provide evidence-based data on TEAS's role in preventing BCRL, potentially integrating Traditional Chinese Medicine with Western medical practices to enhance treatment options.
Limitations:
The study is limited to a specific population and may not generalize to all breast cancer patients, which could affect the applicability of the findings.
Potential biases in participant selection and adherence to treatment protocols may influence the results.
Conclusion:
If effective, TEAS could significantly improve the quality of life for breast cancer patients by reducing the incidence of lymphedema, thereby enhancing overall patient care.
